During the past decade, Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are "Immune Thrombocytopenic Purpura" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" in a lesser frequency.

Most popular intervention types in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BMS-986004 1500 mg IV" (1 trials), "BMS-986004 225 mg IV" (1 trials), "BMS-986004 675 mg IV" (1 trials), "BMS-986004 75 mg IV" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".